The efficacy and safety of endo-radiofrequency for the treatment of hidradenitis suppurativa
© 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd..
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic and recurrent disease of the axilla and groin with inflammatory lesions. There is no definitive medication or intervention to cure the disease. Radiofrequency (RF) is a modality to destroy the lesions by transferring heat into the skin. To date, few studies have been conducted to evaluate the efficacy and safety of RF at HS.
METHODS: This 9-month, prospective, nonrandomized, and single-blinded study is a clinical trial conducted in 10 patients with refractory HS. In all patients, the initial grade of HS was evaluated. The procedure involved treating HS of the axilla with a endo-RF wave device. Post-treatment evaluation included: determination of the severity of the disease by a blinded dermatologist, the degree of patient satisfaction, tolerability in each patient, and complications of the procedure. We also evaluate the recurrence of the disease during a 6-month follow-up.
RESULTS: The satisfaction level after the intervention among under-studied cases was excellent and good in six of cases. There was a significant difference in comparing the grading score of patients before and 3 months after receiving RF (P-value: 0.01). Regarding tolerability, eight of the patients could tolerate it. We had no complication after the intervention and four cases had not recurrence during a 6-month follow-up.
CONCLUSION: Endo-RF is an effective and safe modality for treating HS however to prevent the recurrence, periodic therapy sessions are needed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) - 29(2023), 9 vom: 27. Sept., Seite e13450 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Behrangi, Elham [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical trial |
|---|
| Anmerkungen: |
Date Revised 29.09.2023 published: Print Citation Status Publisher |
|---|
| doi: |
10.1111/srt.13450 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362500126 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362500126 | ||
| 003 | DE-627 | ||
| 005 | 20231226091355.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/srt.13450 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1208.xml |
| 035 | |a (DE-627)NLM362500126 | ||
| 035 | |a (NLM)37753687 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Behrangi, Elham |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The efficacy and safety of endo-radiofrequency for the treatment of hidradenitis suppurativa |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd. | ||
| 520 | |a BACKGROUND: Hidradenitis suppurativa (HS) is a chronic and recurrent disease of the axilla and groin with inflammatory lesions. There is no definitive medication or intervention to cure the disease. Radiofrequency (RF) is a modality to destroy the lesions by transferring heat into the skin. To date, few studies have been conducted to evaluate the efficacy and safety of RF at HS | ||
| 520 | |a METHODS: This 9-month, prospective, nonrandomized, and single-blinded study is a clinical trial conducted in 10 patients with refractory HS. In all patients, the initial grade of HS was evaluated. The procedure involved treating HS of the axilla with a endo-RF wave device. Post-treatment evaluation included: determination of the severity of the disease by a blinded dermatologist, the degree of patient satisfaction, tolerability in each patient, and complications of the procedure. We also evaluate the recurrence of the disease during a 6-month follow-up | ||
| 520 | |a RESULTS: The satisfaction level after the intervention among under-studied cases was excellent and good in six of cases. There was a significant difference in comparing the grading score of patients before and 3 months after receiving RF (P-value: 0.01). Regarding tolerability, eight of the patients could tolerate it. We had no complication after the intervention and four cases had not recurrence during a 6-month follow-up | ||
| 520 | |a CONCLUSION: Endo-RF is an effective and safe modality for treating HS however to prevent the recurrence, periodic therapy sessions are needed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a clinical trial | |
| 650 | 4 | |a efficacy | |
| 650 | 4 | |a hidradenitis suppurativa | |
| 650 | 4 | |a radiofrequency | |
| 650 | 4 | |a safety | |
| 700 | 1 | |a Atefi, Najmolsadat |e verfasserin |4 aut | |
| 700 | 1 | |a Mireshghollah, Pardissadat |e verfasserin |4 aut | |
| 700 | 1 | |a Goodarzi, Azadeh |e verfasserin |4 aut | |
| 700 | 1 | |a Dehghani, Abbas |e verfasserin |4 aut | |
| 700 | 1 | |a Zare Dehnavi, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Roohaninasab, Masoumeh |e verfasserin |4 aut | |
| 700 | 1 | |a Dilmaghani, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Lotfi, Elaheh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) |d 1995 |g 29(2023), 9 vom: 27. Sept., Seite e13450 |w (DE-627)NLM09446216X |x 1600-0846 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2023 |g number:9 |g day:27 |g month:09 |g pages:e13450 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/srt.13450 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2023 |e 9 |b 27 |c 09 |h e13450 | ||